Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Thorax|May 1, 2019
Measuring lung function in airways diseases: current and emerging techniquesNayia Petousi, Nick P Talbot, Ian Pavord, et al.
Advances in Therapy|August 17, 2023
Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe SymptomsDave Singh, Sean Oosterholt, Ian Pavord, et al.
Applied Health Economics and Health Policy|June 30, 2014
Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonistsJenny Willson, Eric D Bateman, Ian Pavord, et al.
Thorax|August 7, 2021
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxideSimon Couillard, Annette Laugerud, Maisha Jabeen, et al.
BMJ Open|January 22, 2022
Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative studyJuliet Foster, Richard Beasley, Irene Braithwaite, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 10, 2019
Severe T2-high asthma in the biologics era: European experts' opinionIan Pavord, Thomas Bahmer, Fulvio Braido, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2025
"Treat-to-Target": A Call for Earlier Targeted Intervention in AsthmaSimon Couillard, Ian Pavord, Flavia Hoyte, et al.
Sensors (Basel, Switzerland)|October 14, 2022
Performance of Contactless Respiratory Rate Monitoring by Albus Home<sup>TM</sup>, an Automated System for Nocturnal Monitoring at Home: A Validation StudyWilliam Do, Richard Russell, Christopher Wheeler, et al.
Annals of Medicine|October 28, 2024
Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension studyIan Pavord, Robert Chan, Nicola Brown, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 5, 2026
Biologics Use in Eosinophilic Lung Disease: Controversies and ConsensusLuis Pérez de Llano, David Dacal Rivas, Ian Pavord, et al.
Pageof 10